Examining the Risk of VTE in Ovarian Cancer
Published research has shown that women with ovarian cancer have among the highest rates of venous...
Dec 15, 2020
Published research has shown that women with ovarian cancer have among the highest rates of venous...
Dec 14, 2020
Although cannabis remains illegal in many parts of the United States, 33 states have approved...
Aug 15, 2020
Leiomyosarcoma (LMS) is a rare gynecologic malignancy, but it contributes to a significant...
Aug 14, 2020
Research indicates that women with early-stage endometrial cancer who have lymphovascular space...
May 26, 2020
ATP citrate lyase (ACLY) is an important enzyme that catalyzes the conversion of citrate to acetyl-CoA in normal cells, facilitating the fatty acid synthesis. Lipids and fatty acids were found to be accumulated in different...
May 26, 2020
The mitochondrial fission protein, Dynamin related protein 1 (Drp1), and its upstream protein calcium/calmodulin-dependent protein kinase I (CaMKI) play a critical role in chemoresistance in ovarian cancer (OVCA). Thus, we...
May 26, 2020
Early-stage ovarian cancer might represent an ideal disease scenario for sentinel lymph node application. Nevertheless, the published experience seems to be limited. Our objective was to assess the feasibility and safety...
May 26, 2020
Epithelial ovarian cancer (EOC) is one of the leading causes of death from gynecologic cancers and peritoneal dissemination is the major cause of death in patients with EOC. Although the loss of 4.1N is associated with increased...
May 26, 2020
The objective of our research was to examine the levels of circulating LOXL1-AS1 in EOC patients and to analyze its diagnostic and prognostic value.The levels of LOXL1-AS1 in 185 EOC patients and 43 healthy volunteers were...
May 12, 2020
Epithelial ovarian cancer is a highly lethal gynecological malignancy. Accurate and cost-effective predictive tools to estimate the prognosis of patients with epithelial ovarian cancer before treatment are currently lacking.The...
May 12, 2020
Treatment of ovarian cancer (OC) remains the biggest challenge among gynecological malignancies. Immune checkpoint blockade therapy is promising in many cancers but shows low response rates in OC because of its heterogeneity....
May 12, 2020
The anticancer, antimicrobial and antiplasmodial activities of six gold(iii) bis(dithiolene) complexes were studied. Complexes 1-6 showed relevant anticancer properties against A2780/A2780cisR ovarian cancer cells (IC50 values...